Eli Lilly's stock may seem expensive now, but holding onto it for long term is beneficial.

From Nasdaq: 2025-02-15 07:30:00

Investors should consider valuations when choosing stocks, as the price can impact returns. Despite a high P/E ratio, Eli Lilly (NYSE: LLY) remains a strong buy due to its growth in revenue and popular GLP-1 drugs. The company is expanding production to meet demand and expects to release a new oral weight loss drug soon. While the stock may seem expensive now, its potential for growth could push its market value to over $1 trillion. Waiting for a lower P/E may result in missed gains, making it a better option to hold onto the stock for long-term benefits.



Read more at Nasdaq: Think Eli Lilly’s Stock Is Expensive? Here’s Why Selling It Now Could Be a Huge Mistake